Realta Investment Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-61
Closed -$7.22K – 395
2026
Q2
$7.22K Sell
61
-3,303
-98% -$357K ﹤0.01% 327
2026
Q1
$349K Buy
3,364
+3,289
+4,385% +$347K 0.12% 146
2025
Q4
$7.84K Buy
+75
New +$7.54K ﹤0.01% 300
2023
Q3
– Sell
-125
Closed -$9.45K – 806
2023
Q2
$9.45K Buy
+125
New +$9.54K ﹤0.01% 729
2023
Q1
– Sell
-125
Closed -$9.82K – 704
2022
Q4
$9.82K Hold
125
– – ﹤0.01% 719
2022
Q3
$9K Buy
+125
New +$9.32K ﹤0.01% 707
2020
Q1
– Sell
-125
Closed -$8K – 1090
2019
Q4
$8K Hold
125
– – ﹤0.01% 1207
2019
Q3
$7K Hold
125
– – ﹤0.01% 1230
2019
Q2
$8K Hold
125
– – ﹤0.01% 1218
2019
Q1
$8K Buy
+125
New +$8.21K ﹤0.01% 970

Other funds holding PJP

Realta Investment Advisors's PJP Position: Q3 2026 in Review

Realta Investment Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2026, closing a stake of 61 shares — an estimated $7.22K sold.

Realta Investment Advisors first reported a position in PJP in Q1 2019 and held it in 10 quarters. The position peaked at $349K in Q1 2026. 13 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Realta Investment Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2026 after selling out during the quarter.
  • Realta Investment Advisors sold 61 Invesco Pharmaceuticals ETF shares in Q3 2026, an estimated $7.22K.
  • Realta Investment Advisors first reported a position in Invesco Pharmaceuticals ETF in Q1 2019 and held it in 10 quarters.
  • Realta Investment Advisors's Invesco Pharmaceuticals ETF position peaked at $349K in Q1 2026.
  • 13 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Realta Investment Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.